Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes
- 1 July 2003
- journal article
- Published by Wiley in The Journal of Pathology
- Vol. 201 (2), 328-333
- https://doi.org/10.1002/path.1429
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pharmacological Inhibition of Diabetic RetinopathyDiabetes, 2001
- Biological effects of aminoguanidine: An updateInflammation Research, 1999
- Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidineDiabetologia, 1998
- Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat modelDiabetologia, 1995
- Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in ratsDiabetologia, 1995
- Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments.British Journal of Ophthalmology, 1994
- Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive ratDiabetologia, 1994
- Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Pathogenetic heterogeneity in retinal capillary basement membrane thickening in the diabetic BB-ratDiabetologia, 1987
- On the Pathogenesis of Diabetic RetinopathyOphthalmology, 1984